Antibe Therapeutics Inc. Reports Year-End Financial And Operating Results
Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV:ATE) filed its financial and operating results today for the fourth quarter and the year ended March 31, 2014.
Antibe’s highlights for the fiscal year included:
•Successfully closing its initial public offering and listing on the TSX Venture Exchange.
Help employers find you! Check out all the jobs and post your resume.